A prospective randomised, open-labeled, trial comparing sirolimus-containing versus mTOR-inhibitor-free immunosuppression in patients undergoing liver transplantation for hepatocellular carcinoma.

MLA

Schnitzbauer, Andreas A., et al. “A Prospective Randomised, Open-Labeled, Trial Comparing Sirolimus-Containing versus MTOR-Inhibitor-Free Immunosuppression in Patients Undergoing Liver Transplantation for Hepatocellular Carcinoma.” BMC Cancer, vol. 10, May 2010, p. 190. EBSCOhost, https://doi.org/10.1186/1471-2407-10-190.

APA

Schnitzbauer, A. A., Zuelke, C., Graeb, C., Rochon, J., Bilbao, I., Burra, P., de Jong, K. P., Duvoux, C., Kneteman, N. M., Adam, R., Bechstein, W. O., Becker, T., Beckebaum, S., Chazouillères, O., Cillo, U., Colledan, M., Fändrich, F., Gugenheim, J., Hauss, J. P., … Geissler, E. K. (2010). A prospective randomised, open-labeled, trial comparing sirolimus-containing versus mTOR-inhibitor-free immunosuppression in patients undergoing liver transplantation for hepatocellular carcinoma. BMC Cancer, 10, 190. https://doi.org/10.1186/1471-2407-10-190

Chicago

Schnitzbauer, Andreas A, Carl Zuelke, Christian Graeb, Justine Rochon, Itxarone Bilbao, Patrizia Burra, Koert P de Jong, et al. 2010. “A Prospective Randomised, Open-Labeled, Trial Comparing Sirolimus-Containing versus MTOR-Inhibitor-Free Immunosuppression in Patients Undergoing Liver Transplantation for Hepatocellular Carcinoma.” BMC Cancer 10 (May): 190. doi:10.1186/1471-2407-10-190.